TVTX Short Interest
Travere Therapeutics, Inc.
1W: -2.7%
1M: -17.4%
3M: -8.4%
YTD: +28.7%
1Y: +81.3%
3Y: +603.7%
5Y: +107.1%
$50.88
+0.91 (+1.82%)
Weekly Expected Move ±6.1%
$44
$47
$50
$53
$56
Credit Risk of going bust: higher than 56% of companies Debt: 11.4% of company value Bonds: $101.5M held by 42 funds → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.80 (down 98%), Travere Therapeutics, Inc. would be worth roughly what it owes.
Total debt $616.9M against a stock market value of $4.80B.
Distance to default 4.60 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $307.6M (short-term plus half of long-term), stock volatility 61.8%; Altman Z'' -2.95. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $0.80 (down 98%), Travere Therapeutics, Inc. would be worth roughly what it owes.
Total debt $616.9M against a stock market value of $4.80B.
Distance to default 4.60 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $307.6M (short-term plus half of long-term), stock volatility 61.8%; Altman Z'' -2.95. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Short Volume Summary
2026-10-2627.9%
Short Ratio
of total volume
60.8%
20-Day Avg
60.8%
50-Day Avg
▼ Falling
5-Day Trend
0.3M
Short Volume
1.0M
Total Volume
Daily Short Volume Ratio
Short Volume vs Total Volume
Exchange Breakdown
2026-10-26| Exchange | Short Volume | Total Volume | Short % |
|---|---|---|---|
| NASDAQ | 277,239 | 1,016,575 | 27.3% |
| NYSE | 15,720 | 30,479 | 51.6% |
| BATS | 24 | 2,231 | 1.1% |